OROmar I. Ramadan

Omar I. Ramadan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Omar I. Ramadan has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Racial, Socioeconomic, and Geographic Disparities in Preamputation Vascular Care for Patients With Chronic Limb-Threatening Ischemia

    by Omar I. Ramadan, Lin Yang, Kaitlyn Shultz, Elizabeth Genovese, Scott M. Damrauer, Grace J. Wang, Eric A. Secemsky, Diane J. Treat-Jacobson, Robin J. Womeodu, Foluso A. Fakorede, et al.

    BACKGROUND: Black patients, those with low socioeconomic status (SES), and those living in rural areas have elevated rates of major lower extremity amputation, which may be related to a lack of subspecialty chronic limb-threatening ischemia care. We evaluated the association between race, rurality, SES, and preamputation vascular care. METHODS: Among patients aged 66 to 86 years with fee-for-service Medicare who underwent major lower extremity amputation for chronic limb-threatening ischemia from July 2010 to December 2019, we compared the proportion who received vascular care in the 12 months before amputation by race (Black versus White), rurality, and SES (dual eligibility for Medicaid versus no dual eligibility) using multivariable logistic regression adjusting for clinical and demographic covariates. RESULTS: Among 73 237 patients who underwent major lower extremity amputation, 40 320 (55.1%) had an outpatient vascular subspecialist visit, 60 109 (82.1%) had lower extremity arterial testing, and 28 345 (38.7%) underwent lower extremity revascularization in the year before amputation. Black patients were less likely to have an outpatient vascular specialist visit (adjusted odds ratio [adjOR], 0.87 [95% CI, 0.84–0.90]) or revascularization (adjOR, 0.90 [95% CI, 0.86–0.93]) than White patients. Compared with patients without low SES or residing in urban areas, patients with low SES or residing in rural areas were less likely to have an outpatient vascular specialist visit (adjOR, 0.62 [95% CI, 0.60–0.64]; low SES versus nonlow SES; adjOR, 0.82 [95% CI, 0.79–0.85]; rural versus urban), lower extremity arterial testing (adjOR, 0.78 [95% CI, 0.75–0.81]; low SES versus nonlow SES; adjOR, 0.90 [95% CI, 0.0.86–0.94]; rural versus urban), or revascularization (adjOR, 0.65 [95% CI, 0.63–0.67]; low SES versus nonlow SES; adjOR, 0.89 [95% CI, 0.86–0.93]; rural versus urban). CONCLUSIONS: Black race, rural residence, and low SES are associated with failure to receive subspecialty chronic limb-threatening ischemia care before amputation. To reduce disparities in amputation, multilevel interventions to facilitate equitable chronic limb-threatening ischemia care are needed.


  • Evaluating patient experience with a surgical navigation program for under-resourced patients

    by Linda M. Saikali, Christopher D. Herrera, Angela T. Chen, Gina Lepore, Omar I. Ramadan, Doreen Lam, Aaron Anandarajah, Carrie Z. Morales, Matthew Goldshore, Jon B. Morris, et al.


  • Emergency Medicaid enrollment after traumatic injury predicts long-term health care utilization

    by Diane N. Haddad, Ella Bs Eisinger, Justin S. Md Hatchimonji, Angela T. Ma Chen, Omar I. Md Ramadan, Anna U. Md Morgan, Deacon J. Lile, M. Kit Delgado, James Reese, Mark J. Seamon, et al.

    BACKGROUND: Injured patients have high rates of uninsurance, which is associated with worse outcomes. Insurance linkage programs that connect patients to Medicaid coverage can prevent catastrophic costs for patients. Less is known about the long-term impact of insurance enrollment. We examined health care utilization for previously uninsured patients, hypothesizing that newly insured patients postinjury would use health care more than those remaining uninsured. METHODS: We linked institutional trauma registry data to the electronic medical record to identify injured patients aged 18 to 64 years from 2017 to 2021. Patients admitted without insurance and then retroactively insured (RI) during hospitalization were compared with patients with preestablished Medicaid (Medicaid insured [MI]) and those remaining uninsured. We compared demographic and injury characteristics and future health care utilization, including hospitalizations, emergency department (ED) visits, and clinic visits, among groups at 30 days and 12 months postinjury. Patient-reported outcomes (PROs) 6 months after injury were compared by group for a subset of patients participating in an ongoing study of long-term PROs. RESULTS: We compared 494 RI patients with 1,706 MI and 148 uninsured patients. Retroactively insured patients were younger, more likely to have penetrating injuries, and longer hospitalization than other groups. There was a significant increase in ED and clinic visits and hospital admissions at 30 days and 12 months between RI and uninsured patients (p < 0.001). Using multivariable logistic regression, RI was associated with higher future ED utilization, hospital admissions, and specialist visits at 30 days and 12 months compared with uninsured patients. Of the 265 patients with 6-month PROs, Medicaid coverage was not associated with any significant difference in physical function or anxiety. CONCLUSION: Patients enrolled in insurance postinjury are more likely to use health care in the future than patients without insurance, but the downstream effects are less clear. Health insurance is a necessary step but not independently sufficient to optimize care and improve health outcomes. LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.


  • Open Access

    Association Between Diagnosis‐to‐Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb‐Threatening Ischemia: Insights From the CLIPPER Cohort

    by Alexander C. Fanaroff, Elias J. Dayoub, Lin Yang, Kaitlyn Schultz, Omar I. Ramadan, Grace J. Wang, Scott M. Damrauer, Elizabeth A. Genovese, Eric A. Secemsky, Sahil A. Parikh, et al.

    Background: The extent and consequences of ischemia in patients with chronic limb‐threatening ischemia (CLTI) may change rapidly, and delays from diagnosis to revascularization may worsen outcomes. We sought to describe the association between time from diagnosis to endovascular lower extremity revascularization (diagnosis‐to‐limb revascularization [D2L] time) and clinical outcomes in outpatients with CLTI. Methods and Results: In the CLIPPER cohort, comprising patients between 66 and 86 years old diagnosed with CLTI betweeen 2010 and 2019, we used Medicare claims data to identify patients who underwent outpatient endovascular revascularization within 180 days of diagnosis. We described the risk‐adjusted association between D2L time and clinical outcomes. Among 1 130 065 patients aged between 66 and 86 years with CLTI, 99 221 (8.8%) underwent outpatient endovascular lower extremity revascularization within 180 days of their CLTI diagnosis. Among patients with D2L time 30 days, each additional 10‐day increase in D2L time was associated with a 2.5% greater risk of major amputation (hazard ratio, 1.025 [95% CI, 1.014–1.036]). There was no association between D2L time and all‐cause death. Conclusions: A delay of >30 days from CLTI diagnosis to lower extremity endovascular revascularization was associated with an increased risk of major lower extremity amputation among patients undergoing outpatient endovascular revascularization. Improving systems of care to reduce D2L time could reduce amputations.


  • Impact of Hospital Affiliation With a Flagship Hospital System on Surgical Outcomes

    by Omar I. Md Ramadan, Paul R. Rosenbaum, Joseph G. Reiter, Siddharth DrPH Jain, Alexander S. Bs Hill, Sean Bs Hashemi, Rachel R. Md Kelz, Lee A. Fleisher, Jeffrey H. Silber

    Objective: To compare general surgery outcomes at flagship systems, flagship hospitals, and flagship hospital affiliates versus matched controls. Summary Background Data: It is unknown whether flagship hospitals perform better than flagship hospital affiliates for surgical patients. Methods: Using Medicare claims for 2018 to 2019, we matched patients undergoing inpatient general surgery in flagship system hospitals to controls who underwent the same procedure at hospitals outside the system but within the same region. We defined a “flagship hospital” within each region as the major teaching hospital with the highest patient volume that is also part of a hospital system; its system was labeled a “flagship system.” We performed 4 main comparisons: patients treated at any flagship system hospital versus hospitals outside the flagship system; flagship hospitals versus hospitals outside the flagship system; flagship hospital affiliates versus hospitals outside the flagship system; and flagship hospitals versus affiliate hospitals. Our primary outcome was 30-day mortality. Results: We formed 32,228 closely matched pairs across 35 regions. Patients at flagship system hospitals (32,228 pairs) had lower 30-day mortality than matched control patients [3.79% vs. 4.36%, difference=−0.57% (−0.86%, −0.28%), PP<0.001]. Conclusions: Patients treated at flagship hospitals had significantly lower mortality rates than those treated at flagship hospital affiliates. Hence, flagship system affiliation does not alone imply better surgical outcomes.


  • Incorporation and Utilization of an Additional Needs Screener by Surgical Trainees for Comprehensive Care of Underserved and Underinsured Surgical Patients

    by Stephen Halada, Angela T. Chen, Omar I. Ramadan, Eric H. Li, Matthew Goldshore, Jon B. Morris, Carrie Z. Morales


  • Open Access

    Development and Description of a National Cohort of Patients With Chronic Limb-Threatening Ischemia

    by Alexander C. Fanaroff, Elias J. Dayoub, Lin Yang, Kaitlyn Shultz, Omar I. Ramadan, Elizabeth A. Genovese, Grace J. Wang, Scott M. Damrauer, Eric A. Secemsky, Sahil A. Parikh, et al.


  • Open Access

    LB-7 | Development & Baseline Characteristics of a 1.13M-Patient Longitudinal Cohort to Assess CLTI Quality of Care

    by Alexander Fanaroff, Elias Dayoub, Lin Yang, Kaitlyn Shultz, Omar Ramadan, Grace Wang, Scott Damrauer, Eric Secemsky, Sahil A. Parikh, Ashwin Nathan, et al.


  • Impact of Medicaid expansion on outcomes after abdominal aortic aneurysm repair

    by Omar I. Ramadan, Rachel R. Kelz, James E. Sharpe, Christopher J. Wirtalla, Luke J. Keele, Michael O. Harhay, Sanford E. Roberts, Grace J. Wang


  • Redefining Multimorbidity in Older Surgical Patients

    by Omar I Ramadan, Paul R Rosenbaum, Joseph G Reiter, Siddharth DrPH Jain, Alexander S Bs Hill, Sean Bs Hashemi, Rachel R Md Kelz, Lee A Fleisher, Jeffrey H Silber

    BACKGROUND: Multimorbidity in surgery is common and associated with worse postoperative outcomes. However, conventional multimorbidity definitions (≥2 comorbidities) label the vast majority of older patients as multimorbid, limiting clinical usefulness. We sought to develop and validate better surgical specialty-specific multimorbidity definitions based on distinct comorbidity combinations. STUDY DESIGN: We used Medicare claims for patients aged 66 to 90 years undergoing inpatient general, orthopaedic, or vascular surgery. Using 2016 to 2017 data, we identified all comorbidity combinations associated with at least 2-fold (general/orthopaedic) or 1.5-fold (vascular) greater risk of 30-day mortality compared with the overall population undergoing the same procedure; we called these combinations qualifying comorbidity sets. We applied them to 2018 to 2019 data (general = 230,410 patients, orthopaedic = 778,131 patients, vascular = 146,570 patients) to obtain 30-day mortality estimates. For further validation, we tested whether multimorbidity status was associated with differential outcomes for patients at better-resourced (based on nursing skill-mix, surgical volume, teaching status) hospitals vs all other hospitals using multivariate matching. RESULTS: Compared with conventional multimorbidity definitions, the new definitions labeled far fewer patients as multimorbid: general = 85.0% (conventional) vs 55.9% (new) (p < 0.0001); orthopaedic = 66.6% vs 40.2% (p < 0.0001); and vascular = 96.2% vs 52.7% (p < 0.0001). Thirty-day mortality was higher by the new definitions: general = 3.96% (conventional) vs 5.64% (new) (p < 0.0001); orthopaedic = 0.13% vs 1.68% (p < 0.0001); and vascular = 4.43% vs 7.00% (p < 0.0001). Better-resourced hospitals offered significantly larger mortality benefits than all other hospitals for multimorbid vs nonmultimorbid general and orthopaedic, but not vascular, patients (general surgery difference-in-difference = ˗0.94% [˗1.36%, ˗0.52%], p < 0.0001; orthopaedic = ˗0.20% [˗0.34%, ˗0.05%], p = 0.0087; and vascular = ˗0.12% [˗0.69%, 0.45%], p = 0.6795). CONCLUSIONS: Our new multimorbidity definitions identified far more specific, higher-risk pools of patients than conventional definitions, potentially aiding clinical decision-making. Export